✦ LIBER ✦

Bucindolol has no overall survival benefit for advanced chronic heart failure

✍ Scribed by Åke Hjalmarson

Book ID: 119763753
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 225 KB
Volume: 5
Category: Article
ISSN: 1361-2611
DOI: 10.1054/ebcm.2001.0402

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1637 CHRONIC KIDNEY DISEASE AFTER PARITA

1637 CHRONIC KIDNEY DISEASE AFTER PARITAL NEPHRECTOMY FOR RENAL CELL CARCINOMA: IS THERE AN OVERALL SURVIVAL BENEFIT IN ADVANCED AGE?

✍ Kyung, Yoon Soo; Song, Sang Hoon; Lim, Ju Hyun; Moon, Kyung Hyun; You, Dalsan; J 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 87 KB

ASSESSMENT OF THE SURVIVAL BENEFITS OF L

ASSESSMENT OF THE SURVIVAL BENEFITS OF LISTING ADVANCED HEART FAILURE FOR HEART TRANSPLANTATION THROUGH A MONTE CARLO MICROSIMULATION MODEL

✍ Santiago Gabriel Miriuka; Rosana Poggio; Christian Caroli; Mariano Giorgi; Herná 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 273 KB

Neoadjuvant therapy for breast cancer ha

Neoadjuvant therapy for breast cancer has no benefits on overall survival or on the mastectomy rate in routine clinical practice. A population-based study with a median follow-up of 11 years using propensity score matching

✍ I. Le Ray; S. Dabakuyo; G. Crehange; M. Bardou; L. Arnould; J. Fraisse; P. Fumol 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 496 KB